| 英文别名 |
Tasimelteon;(1R-trans)-N-[[2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide;BMS 214778;N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide;BMS-214778;Hetlioz;MA 1;UNII-SHS4PU80D9;VEC-162;(1R, 2R)-N-[2- (2,3-Dihydrobenzofuran-4-yl)cyclopropylmethyl]propanamide;N-[[(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide;VEC 162;SHS4PU80D9;N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide;Tasimelteon [USAN:INN];tasimelteonum;N-([(1r,2r)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl)propanamide;N-(((1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl)methyl)propanamide;Hetlioz (TN);Tasimelteon (USAN/INN);DTXSID70209826;BMS214778;TASIMELTEON [MI];SCHEMBL3505912;Propanamide, N-(((1R,2R)-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)-;EN300-20605494;NS00034514;PTOIAAWZLUQTIO-GXFFZTMASA-N;DB09071;Tasimelteon [USAN];N05CH03;EX-A2729;AKOS025149360;TASIMELTEON [WHO-DD];HETLIOZ LQ;TASIMELTEON (MART.);BMS-214778;VEC-162;HetliozLQ;AMY6925;BMS-214,778;CHEMBL2103822;TASIMELTEON [INN];(-)-(trans)-N-[[2-(2,3-Dihydrobenzofuran-4-yl)cycloprop-1-yl] methyl]propanamide;CHEBI:79042;HMS3885L17;HY-14803;AC-6143;N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide;NCGC00522560-01;609799-22-6;CS-5512;TASIMELTEON [MART.];(trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl) cyclopropyl]methyl]propanamide;BCP07180;MFCD09033789;s4281;CCG-266915;DTXCID20132317;D09388;GTPL7393;Tasimelteon, >=98% (HPLC);TASIMELTEON [VANDF];TASIMELTEON [ORANGE BOOK];N-(((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide;T3813;(trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide;Q7687250;AS-35291;BRD-K62971431-001-01-9;BRD-K62971431-001-01-9 |